BIOLASE
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BIOLASE generated cash of -$14,091,000, which is more than the previous year. Cash used in financing activities reached the amount of $17,434,000 last year. Net change in cash is therefore $2,385,000.
Cash Flow
| 2014 | -16.20M | -197K | 46.75M |
|---|---|---|---|
| 2015 | -17.77M | -1.77M | -105K |
| 2016 | -10.64M | -1.41M | 9.35M |
| 2017 | -18.41M | -747K | 21.61M |
| 2018 | -14.14M | -522K | 11.23M |
| 2019 | -12.74M | -207K | 10.72M |
| 2020 | -12.79M | -96K | 24.34M |
| 2021 | -16.71M | -707K | 29.95M |
| 2022 | -26.76M | -3.72M | 4.60M |
| 2023 | -14.09M | -1.12M | 17.43M |
BIOL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.18M | 30.17M | 17.87M | 6.10M | 8.35M | 11.89M | 8.92M | 11.69M | 31.56M | 1.44M |
Operating activities | ||||||||||
Net income | -20.63M | -28.63M | -16.15M | -16.82M | -17.85M | -21.51M | -16.85M | -15.37M | -20.27M | -18.92M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.79M | 497K | 400K | 499K | 982K | 945K | 1.20M | 1.04M | 880K | 696K |
Stock-based compensation expense | 1.23M | 2.30M | 1.66M | 3.37M | 2.74M | 0 | 2.20M | 3.06M | 3.35M | 1.23M |
| Deferred income tax benefit | 1.23M | 2.30M | 1.66M | 3.37M | 2.74M | 0 | 2.20M | 3.06M | 3.35M | 1.23M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 201K | -1.64M | -978K | 4.28M | 655K | -1.45M | -337K | -644K | -52K | 826K |
Inventories | 969K | -5.75M | -1.37M | -871K | 840K | -127K | 419K | -1.98M | -705K | -1.71M |
Accounts payable | -1.85M | 3.52M | 2.05M | -2.10M | -2.71M | 1.76M | -5.00M | 3.32M | -640K | 451K |
Cash generated by operating activities | -14.09M | -26.76M | -16.71M | -12.79M | -12.74M | -14.14M | -18.41M | -10.64M | -17.77M | -16.20M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.31M | -3.72M | -707K | -96K | -207K | -558K | -747K | -1.41M | -1.80M | -198K |
Acquisitions Net | 182K | 0 | 0 | 0 | 0 | 36K | 0 | 0 | 25K | 0 |
Cash generated by investing activities | -1.12M | -3.72M | -707K | -96K | -207K | -522K | -747K | -1.41M | -1.77M | -197K |
Financing activities | ||||||||||
Common Stock Issued | 9.55M | 5.60M | 29.97M | 6.91M | 9.17M | -161K | 21.76M | 9.52M | 44K | 51.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 17.37M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -165K | -1M | 0 | -3.7M | 2.5M | -3.74M | -146K | -171K | -107K | -21.50M |
Cash used in financing activities | 17.43M | 4.60M | 29.95M | 24.34M | 10.72M | 11.23M | 21.61M | 9.35M | -105K | 46.75M |
Net Change In Cash | 2.38M | -25.99M | 12.29M | 11.77M | -2.25M | -3.54M | 2.72M | -2.77M | -19.86M | 30.12M |
Cash at end of period | 6.56M | 4.18M | 30.17M | 17.87M | 6.10M | 8.35M | 11.64M | 8.92M | 11.69M | 31.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |